A pszichotikus kórképek gyógyszerei (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "A pszichotikus kórképek gyógyszerei" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

4doi.org

2^nd place

8^th place

4nih.gov

4^th place

11^th place

3sciencedirect.com

149^th place

249^th place

1google.hu

8,839^th place

51^st place

1tankonyvtar.hu

low place

68^th place

1rcpsych.org

low place

9,879^th place

1medical-hypotheses.com

low place

1infona.pl

low place

1sagepub.com

731^st place

2,041^st place

1apa.org

1,220^th place

1,474^th place

1plos.org

2,112^th place

3,022^nd place

1nature.com

234^th place

267^th place

1wiley.com

222^nd place

312^th place

1web.archive.org

1^st place

1drdiag.hu

low place

1,861^st place

apa.org

psycnet.apa.org

Morais SL, Guimarães FS, Mechoulam R. Antipsychotic effect of cannabidiol. J Clin Psychiatry. 1995, 56; 485–6.

doi.org

dx.doi.org

(2011) „The introduction of chlorpromazine in Belgium and the Netherlands (1951-1968); tango between old and new treatment features”. Stud Hist Philos Biol Biomed Sci 42 (4), 443–52. o. DOI:10.1016/j.shpsc.2011.05.003. PMID 22035718.
(2005) „Understanding and treating depersonalisation disorder”. Advances in Psychiatric Treatment 11 (2), 92–100. o, Kiadó: Royal College of Psychiatrists. DOI:10.1192/apt.11.2.92.
(2005. szeptember 1.) „Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription”. Br J Psychiatry 187 (3), 243–7. o. DOI:10.1192/bjp.187.3.243. PMID 16135861.
(1988. március 1.) „Antipsychotic withdrawal symptoms: phenomenology and pathophysiology”. Acta Psychiatr Scand 77 (3), 241–6. o. DOI:10.1111/j.1600-0447.1988.tb05116.x. PMID 2899377.

drdiag.hu

Dr. Diag.hu Malignus neuroleptikus szindróma. [2016. június 4-i dátummal az eredetiből archiválva]. (Hozzáférés: 2016. augusztus 8.)

google.hu

books.google.hu

Valenstein, Elliot. Blaming the brain: The truth about drugs and mental health. Simon and Schuster, 2002.

infona.pl

Tsopelas, C., et al. "Use of cannabis components in the treatment of mental disorders." European Psychiatry 33 (2016): S685.

medical-hypotheses.com

Whitaker, Robert. "The case against antipsychotic drugs: a 50-year record of doing more harm than good." Medical hypotheses 62.1 (2004): 5-13.

nature.com

Leweke, F. M., et al. "Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia." Translational psychiatry 2.3 (2012): e94.

nih.gov

ncbi.nlm.nih.gov

(2011) „The introduction of chlorpromazine in Belgium and the Netherlands (1951-1968); tango between old and new treatment features”. Stud Hist Philos Biol Biomed Sci 42 (4), 443–52. o. DOI:10.1016/j.shpsc.2011.05.003. PMID 22035718.
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults". J Am Geriatr Soc. 60 (4): 616–31. April 2012.
(2005. szeptember 1.) „Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription”. Br J Psychiatry 187 (3), 243–7. o. DOI:10.1192/bjp.187.3.243. PMID 16135861.
(1988. március 1.) „Antipsychotic withdrawal symptoms: phenomenology and pathophysiology”. Acta Psychiatr Scand 77 (3), 241–6. o. DOI:10.1111/j.1600-0447.1988.tb05116.x. PMID 2899377.

plos.org

journals.plos.org

Breuer, Aviva, et al. "Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects." PloS one 11.7 (2016): e0158779.

rcpsych.org

apt.rcpsych.org

(2005) „Understanding and treating depersonalisation disorder”. Advances in Psychiatric Treatment 11 (2), 92–100. o, Kiadó: Royal College of Psychiatrists. DOI:10.1192/apt.11.2.92.

sagepub.com

jop.sagepub.com

Zuardi, Antonio Waldo, et al. "Cannabidiol monotherapy for treatment-resistant schizophrenia." Journal of Psychopharmacology 20.5 (2006): 683-686.

sciencedirect.com

tankonyvtar.hu

Gyires Klára, Fürst Zsuzsanna, A farmakológia alapjai (2011)

web.archive.org

Dr. Diag.hu Malignus neuroleptikus szindróma. [2016. június 4-i dátummal az eredetiből archiválva]. (Hozzáférés: 2016. augusztus 8.)

wiley.com

onlinelibrary.wiley.com

Deiana, Serena. "Medical use of cannabis. Cannabidiol: a new light for schizophrenia?." Drug testing and analysis 5.1 (2013): 46-51.